Kate M. Moore

977 total citations
11 papers, 535 citations indexed

About

Kate M. Moore is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Kate M. Moore has authored 11 papers receiving a total of 535 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Immunology. Recurrent topics in Kate M. Moore's work include Immunotherapy and Immune Responses (3 papers), Cell Adhesion Molecules Research (3 papers) and Zebrafish Biomedical Research Applications (2 papers). Kate M. Moore is often cited by papers focused on Immunotherapy and Immune Responses (3 papers), Cell Adhesion Molecules Research (3 papers) and Zebrafish Biomedical Research Applications (2 papers). Kate M. Moore collaborates with scholars based in United Kingdom, United States and Finland. Kate M. Moore's co-authors include Alexander Medvinsky, Clare Blackburn, Erin B. Taylor, Samir Taoudi, Julie M. Sheridan, Malgorzata Sobiesiak, Sabrina Gordon-Keylock, Stanislav Rybtsov, John F. Marshall and David Cameron and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and JNCI Journal of the National Cancer Institute.

In The Last Decade

Kate M. Moore

10 papers receiving 534 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kate M. Moore United Kingdom	8	298	262	154	115	101	11	535
Taher E.I. Taher Netherlands	8	160 0.5×	307 1.2×	116 0.8×	51 0.4×	141 1.4×	9	597
JE Visvader Australia	6	244 0.8×	537 2.0×	117 0.8×	212 1.8×	110 1.1×	13	723
Fredrik Ellin Sweden	8	198 0.7×	230 0.9×	163 1.1×	49 0.4×	226 2.2×	22	676
Jamie E. Siefring United States	6	142 0.5×	354 1.4×	278 1.8×	154 1.3×	113 1.1×	7	678
Johanna Melo‐Cardenas United States	13	212 0.7×	398 1.5×	160 1.0×	67 0.6×	122 1.2×	26	701
Chelsea Hope United States	10	103 0.3×	193 0.7×	169 1.1×	130 1.1×	205 2.0×	18	475
Yi-Fen Lu United States	8	212 0.7×	362 1.4×	121 0.8×	139 1.2×	73 0.7×	10	525
W Keeble United States	8	85 0.3×	245 0.9×	137 0.9×	105 0.9×	142 1.4×	8	481
Françoise Le Pesteur France	9	141 0.5×	210 0.8×	175 1.1×	301 2.6×	88 0.9×	9	514
Aline M. Morrison Austria	7	321 1.1×	253 1.0×	218 1.4×	209 1.8×	55 0.5×	9	598

Countries citing papers authored by Kate M. Moore

Since Specialization

Citations

This map shows the geographic impact of Kate M. Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kate M. Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kate M. Moore more than expected).

Fields of papers citing papers by Kate M. Moore

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kate M. Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kate M. Moore. The network helps show where Kate M. Moore may publish in the future.

Co-authorship network of co-authors of Kate M. Moore

This figure shows the co-authorship network connecting the top 25 collaborators of Kate M. Moore. A scholar is included among the top collaborators of Kate M. Moore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kate M. Moore. Kate M. Moore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Moore, Kate M., Kenneth G. MacLeod, Peter Mullen, et al.. (2022). Collateral-resistance to estrogen and HER-activated growth is associated with modified AKT, ERα, and cell-cycle signaling in a breast cancer model. SHILAP Revista de lepidopterología. 3. 97–116. 1 indexed citations

Raj, Deepak B. Thimiri Govinda, Kate M. Moore, Nicholas F. Brown, et al.. (2021). CEACAM7 Is an Effective Target for CAR T-cell Therapy of Pancreatic Ductal Adenocarcinoma. Clinical Cancer Research. 27(5). 1538–1552. 42 indexed citations

Moore, Kate M., Ami V. Desai, Beatriz de Luxán‐Delgado, et al.. (2020). Integrin αvβ6-specific therapy for pancreatic cancer developed from foot-and-mouth-disease virus. Theranostics. 10(7). 2930–2942. 37 indexed citations

Caley, Matthew, Vera Martins, Kate M. Moore, et al.. (2020). Loss of the laminin subunit alpha‐3 induces cell invasion and macrophage infiltration in cutaneous squamous cell carcinoma*. British Journal of Dermatology. 184(5). 923–934. 9 indexed citations

Carter, Edward, Edmund H. Wilkes, Ann‐Marie Baker, et al.. (2018). PHLDA1 Mediates Drug Resistance in Receptor Tyrosine Kinase-Driven Cancer. Cell Reports. 22(9). 2469–2481. 38 indexed citations

Martins, Vera, Matthew Caley, Kate M. Moore, et al.. (2015). Suppression of TGF_βand Angiogenesis by Type VII Collagen in Cutaneous SCC. JNCI Journal of the National Cancer Institute. 108(1). djv293–djv293. 70 indexed citations

Gordon-Keylock, Sabrina, Malgorzata Sobiesiak, Stanislav Rybtsov, Kate M. Moore, & Alexander Medvinsky. (2013). Mouse extraembryonic arterial vessels harbor precursors capable of maturing into definitive HSCs. Blood. 122(14). 2338–2345. 76 indexed citations

Taoudi, Samir, Kate M. Moore, Julie M. Sheridan, et al.. (2008). Extensive Hematopoietic Stem Cell Generation in the AGM Region via Maturation of VE-Cadherin+CD45+ Pre-Definitive HSCs. Cell stem cell. 3(1). 99–108. 215 indexed citations

Naughton, Catherine, Kate M. Moore, Kenneth G. MacLeod, et al.. (2006). Endocrine therapy resistance can be associated with high estrogen receptor α (ERα) expression and reduced ERα phosphorylation in breast cancer models. Endocrine Related Cancer. 13(4). 1121–1133. 44 indexed citations

10.

Mathias, Lon J., et al.. (2003). Supramolecular Materials from Multifunctional Pyroglutamic Acid Derivatives. Macromolecules. 36(12). 4250–4252. 2 indexed citations

11.

James, K., et al.. (1981). Tumour-associated immunoglobulins and host cell infiltration. Cancer Immunology Immunotherapy. 10-10(2-3). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact